IceCure Medical Stock (NASDAQ:ICCM)
Previous Close
$0.61
52W Range
$0.48 - $1.57
50D Avg
$0.63
200D Avg
$0.91
Market Cap
$29.83M
Avg Vol (3M)
$624.81K
Beta
2.63
Div Yield
-
ICCM Company Profile
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
ICCM Performance
Peer Comparison
Ticker | Company |
---|---|
CTSO | Cytosorbents Corporation |
SGHT | Sight Sciences, Inc. |
SSKN | STRATA Skin Sciences, Inc. |
ITGR | Integer Holdings Corporation |
CLPT | ClearPoint Neuro, Inc. |
NPCE | NeuroPace, Inc. |
TELA | TELA Bio, Inc. |
BWAY | BrainsWay Ltd. |
SRDX | Surmodics, Inc. |
KIDS | OrthoPediatrics Corp. |
OSA | ProSomnus, Inc. Common Stock |
ESTA | Establishment Labs Holdings Inc. |
TNON | Tenon Medical, Inc. |
SINT | Sintx Technologies, Inc. |
CNMD | CONMED Corporation |